Neuroligin-Neurexin Interaction: Difference between revisions

David Canner (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(22 intermediate revisions by one other user not shown)
Line 1: Line 1:
<StructureSection load='' size='500' side='right' caption='Structure of Neurexin and Neuroligin, [[2wqz]]' scene='Neuroligin-Neurexin_Interaction/Opening/1'>
<StructureSection load='' size='500' side='right' caption='Structure of Neurexin LNS domain (yellow) and Neuroligin (green), [[2wqz]]' scene='Neuroligin-Neurexin_Interaction/Opening/1'>
[[Image:NRXNNLGN2.png|250px|left]]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;'''Neurexins''' ('''NRXNs''') and '''Neuroligins''' ('''NLGNs''') are synaptic cell-adhesion molecules that connect presynaptic and postsynaptic neurons at synapses. NLGNs, of which NLGN1-5 are the best characterized, are endogenous NRXN ligands.<ref name="Chih">PMID:15681343</ref> Upon binding NRXN, NLGNs mediate signaling across the synapse, and shape the properties of neural networks by specifying synaptic functions. Early experiments proved that NLGNs function at synapses by showing that NLGNs expressed in non-neuronal cells can induce co-cultured neurons to form presynaptic specializations onto the non-neuronal cell. The same is true for NRXNs which formed postsynaptic specializations.<ref name="Sudhof">PMID:18923512</ref> Subsequent analysis of gene-knockout mice surprisingly revealed that NLGNS and NRXNs are essential for synaptic function and organization, but not synapse formation.<ref name="Kat">PMID:17823315</ref> In effect, NRXNS and NLGNS shape synaptic efficacy and plasticity.<ref name="Sudhof"/>
[[Image:NRXNNLGN2.png|250px|left]]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;'''Neurexins''' ('''NRXNs''') and '''Neuroligins''' ('''NLGNs''') are synaptic cell-adhesion molecules that form a connection between presynaptic and postsynaptic neurons at synapses. NLGNs, of which NLGN1-5 are the best characterized, are endogenous NRXN ligands.<ref name="Chih">PMID:15681343</ref> Upon binding NRXN, NLGNs mediate signaling across the synapse, recruit neutrotransmitter receptors, and shape neural networks and synaptic functions. Early experiments validated that NLGNs function at synapses by showing that NLGN expression in non-neuronal cells can cause presynaptic specializations to form on co-cultured neurons. The same is true for NRXNs which formed postsynaptic specializations.<ref name="Sudhof">PMID:18923512</ref> Subsequent analysis of gene-knockout mice surprisingly revealed that NLGNS and NRXNs are essential for synaptic function and organization, although do not appear to be critical for synapse formation.<ref name="Kat">PMID:17823315</ref>  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Experimental results from the past 10 years have revealed that loss of Neuroligin function has a selective reductive effect on inhibitory synapse function indicating that functional inhibitory synapses rely more heavily on neuroligins than do excitatory synapses.<ref name="Chih"/> This was an astonishing discovery as [[Autism Spectrum Disorders]] (ASDs) have long been attributed to perturbations in the Excitatory/Inhibitory (E/I) synaptic signal ratios within the brain.  Knockdown studies have validated that the selective knockdown of NLGNs resulted in a significant imbalance of E/I transmission possibly altering oscillatory rhythms in the brain.<ref name="Kat"/><ref name="Chih"/>  As Sudhof et al. point out,  a major reason for the difficitulties in understanding cognitive diseases is that they arise from subtle changes in a subset of synapses as opposed to obvious impairment of all synapses in all circuits.<ref name="Sudhof"/> The altered E/I ratios associated with NLGN dysfunction may be an example of such a “subtle change”.  Indeed, mice with loss-of function mutations in NLGN4 exhibit deficits in social interactions and communication that are reminiscent of ASDs.<ref>PMID:18227507</ref> Of particular interest are those NLGN3 mutations like R451C in which mice have the impaired social ability but elevated learning capacity manifestations reminiscent of “savant” syndrome.<ref name="Kat"/> In all, seven point mutations, two translocations and four large-scale deletions in the NRXN1 gene were detected in patients with autism.<ref name="Sudhof"/> These mutations however were only found in a small percentage of Autism patients and are occasionally present in non-symptomatic siblings. Thus, these mutations may only increase the chance of autism rather than actually causing it.<ref name="Fabrichny">PMID:18093521</ref>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are two <scene name='Neuroligin-Neurexin_Interaction/Neurexin_opening/1'>types of Neurexins</scene>, α and β. While α-NRXNs are much larger than β-NRXNs, both contain a single LNS (Laminin, NRXN, sex-hormone-binding globulin domains) domain. Extensive alternative splicing at five unique positions generates thousands of NRXN isoforms which likely specify a “code” of interactions at synapses that varies by location and activity of the neuron.<ref name="Sudhof"/> All NRXN isoforms have the same <scene name='Neuroligin-Neurexin_Interaction/Jelly_roll/1'>“jelly roll fold”</scene> comprised of 14 beta sheets. The alternative splicing only <scene name='Neuroligin-Neurexin_Interaction/Spliced/1'>impacts one end of the jelly roll</scene>, including sheets 1, 2, 13 & 14 and the lone alpha helix in the LNS domain.<ref>PMID:10520997</ref>
====Neuroligin-Neurexin & Autism====
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Experimental results from the past 10 years have revealed that loss of Neuroligin reduces inhibitory synapse function, indicating that inhibitory synapses rely heavily on neuroligins compared to excitatory synapses.<ref name="Chih"/> It was also discovered that overexpression of neuroligin-1 leads to increased excitatory transmission whereas overexpression of neuroligin-2 leads to a marked increase in inhibitory transmission.<ref name="Sudhof"/> This was an astonishing discovery as [[Autism Spectrum Disorders]] (ASDs) have long been attributed to perturbations in the Excitatory/Inhibitory (E/I) synaptic signal ratios within the brain. Excitatory synapses release excitatory neurotransmitters like glutamate while inhibitory synapses release inhibitory neurotrasnmitters like gamma-aminobutyric acid (GABA). Knockdown studies have validated that the selective knockdown of NLGNs creates a significant E/I transmission imbalance, possibly altering the brain’s oscillatory rhythms.<ref name="Kat"/><ref name="Chih"/> As Sudhof et al. point out,  a major reason for the difficulties in understanding cognitive diseases is that they arise from subtle changes in various subsets of synapses as opposed to obvious impairment of all synapses.<ref name="Sudhof"/> The altered E/I ratios associated with NLGN dysfunction may be an example of such a “subtle change”.  Indeed, mice with non-functional mutated NLGN4 exhibit social interaction and communication defecits that are reminiscent of human ASDs.<ref>PMID:18227507</ref> Of particular interest are those NLGN3 mutations like R451C in which mice have impaired social ability but elevated learning capacity. These manifestations are reminiscent of “savant” syndrome.<ref name="Kat"/> In all, seven point mutations, two translocations and four multi-base deletions in the NRXN1 gene were detected in patients with autism.<ref name="Sudhof"/> These mutations however were only found in a small percentage of Autism patients and are occasionally present in non-symptomatic siblings. Thus, these mutations may only increase the chance of autism rather than actually causing it.<ref name="Fabrichny">PMID:18093521</ref>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_dimer_opening/1'>extracellular residues of NLGNs</scene>, which bind to the LNS domains of both alpha and beta NRXNs with nanomolar affinity, are <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_opening/1'>composed of a single domain</scene> that is homologous with [[acetylcholinesterase]] (AChE).<ref name="Sudhof"/> Neuroligin-4 consists of a twisted <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_helices_and_sheets/3'>12 stranded beta sheet surrounded by 14 alpha helices</scene>. Three intramolecular <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_disulfide/1'>disulfide bridges</scene> between residues Cys110-Cys146, Cys306-Cys317, and Cys476-Cys510, stabilize the structure.  Neuroligins readily <scene name='Neuroligin-Neurexin_Interaction/Dimer/1'>form a dimmer</scene> consisting of two neuroligin subunits100% of the dimer <scene name='Neuroligin-Neurexin_Interaction/Hydrophobic_interactions/1'>interactions are hydrophobic</scene> with the most unique feature being a <scene name='Neuroligin-Neurexin_Interaction/4_helix_bundle/2'>prominent four-helix bundle</scene> (<scene name='Neuroligin-Neurexin_Interaction/4_helix_bundle_hydro/1'>Alternate View</scene>).<ref name="Fabrichny"/> The <scene name='Neuroligin-Neurexin_Interaction/Central_pocket/2'>central pocket within Neuroligin</scene>, which in Acetylcholinesterase contains the active center and oxyanion hole, is catalytically inactive due to a substitution of Gly for Ser <scene name='Neuroligin-Neurexin_Interaction/Central_pocket_gly/1'>at position 254</scene>, which is typically part of AChE’s hydrolytic catalytic triad. The <scene name='Neuroligin-Neurexin_Interaction/Cys_loop/3'>so-called Cys-Loop</scene> (Residues Cys110-Cys146) forms one side of the rim of the central pocket and is a homolog of the lid found in [[Lipase|lipases]] of the α/β-hydrolase fold family. This Cys-Loop blocks the entry of substrate to the central pocket and provides stability to the NLGN structure.<ref name="Fabrichny"/>
====Structure of Neurexin====
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There are two <scene name='Neuroligin-Neurexin_Interaction/Neurexin_opening/1'>types of Neurexins</scene>, α and β. While α-NRXNs are much larger than β-NRXNs, both contain a single LNS (Laminin, NRXN, sex-hormone-binding globulin domains) domain. Alternative splicing at five positions within the NRXN gene creates thousands of NRXN isoforms which specify an interaction “code” at synapses that varies by neuron location and activity.<ref name="Sudhof"/> All NRXN isoforms are found on presynaptic neuron surfaces and have the same <scene name='Neuroligin-Neurexin_Interaction/Jelly_roll/1'>“jelly roll fold”</scene> comprised of 14 beta sheetsThe alternative splicing only <scene name='Neuroligin-Neurexin_Interaction/Spliced/1'>impacts one end of the jelly roll</scene>, including sheets 1, 2, 13 & 14 and the lone alpha helix in the LNS domain.<ref>PMID:10520997</ref>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<scene name='Neuroligin-Neurexin_Interaction/Combo/3'>NRXN-beta-1 is bound</scene> through its <scene name='Neuroligin-Neurexin_Interaction/Combo_hyper/1'>hypervariable loop edge</scene> to the <scene name='Neuroligin-Neurexin_Interaction/Combo_electro/2'>electronegative surface</scene> of the NLGN-4 molecule, <scene name='Neuroligin-Neurexin_Interaction/Combo_total/1'>opposite the Cys-loop</scene>. The NRXN-NLGN interface is established by both indirect and direct interactions. Indirect interactions include <scene name='Neuroligin-Neurexin_Interaction/Calcium/4'>coordination of a divalent calcium cation</scene> by residues Asp 137, Asn 238, Val 154 and Ile 236 of NRXN-Beta1 and residues Gln 359 and Gly 360 of NLGN-4. Direct interactions between NRXN and NLGN include extensive hydrogen bonding and Van der Waals contacts as well as salt bridges between residues NRXN-Arg 109 & NLGN-Glu 270 and NRXN-Arg232 & NLGN Asp 351. The vast majority of these interactions are conserved among all neuroligin types.<ref name="Fabrichny"/>  
====Structure of Neuroligin====
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_dimer_opening/1'>extracellular residues of NLGNs</scene>, which bind to the LNS domains of both alpha and beta NRXNs, are <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_opening/1'>composed of a single domain</scene> that is homologous to [[acetylcholinesterase]] (AChE).<ref name="Sudhof"/>  Neuroligin-4, which is expressed on the surface of postsynaptic neurons, contains a twisted <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_helices_and_sheets/3'>12-stranded beta sheet structure surrounded by 14 alpha helices</scene>. Three <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_disulfide/1'>disulfide bridges</scene> between residues Cys110-Cys146, Cys306-Cys317, and Cys476-Cys510, stabilize the structure.  Neuroligins readily <scene name='Neuroligin-Neurexin_Interaction/Dimer/1'>form dimers</scene>.  Nearly 100% of the dimer <scene name='Neuroligin-Neurexin_Interaction/Hydrophobic_interactions/1'>interactions are hydrophobic</scene> with the most unique feature being a <scene name='Neuroligin-Neurexin_Interaction/4_helix_bundle/2'>prominent four-helix bundle</scene> (<scene name='Neuroligin-Neurexin_Interaction/4_helix_bundle_hydro/1'>Alternate View</scene>).<ref name="Fabrichny"/> The <scene name='Neuroligin-Neurexin_Interaction/Central_pocket/2'>central pocket within Neuroligin</scene>, which in Acetylcholinesterase contains the active center and oxyanion hole, is catalytically inactive due to a Serine to Glycine substitution <scene name='Neuroligin-Neurexin_Interaction/Central_pocket_gly/1'>at position 254</scene>, which is typically part of AChE’s catalytic triad. The <scene name='Neuroligin-Neurexin_Interaction/Cys_loop/3'>so-called Cys-Loop</scene> (Residues Cys110-Cys146) forms one rim of the central pocket and is a homolog of the lid found in [[Lipase|lipases]] of the α/β-hydrolase fold family. This Cys-Loop blocks the entry of substrate to the central pocket and provides stability to the NLGN structure.<ref name="Fabrichny"/>


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Several **point mutations** (R437C (451 in NLGN 3), G99S, K378R, & V403M) within NLGN have been positively linked with Autism Spectrum Disorders. Although these mutations are remote from the NLGN-NRXN interface, conclusions can be drawn as to their impact on the function of NLGN. **Arg437Cys**, a mutation shown to result in “savant” like attributes in mice, is believed to increase retention of NLGN in the endoplasmic reticulum preventing correct positioning at the cell surface. It could also disrupt a dense network of charged residues (Asp 388, Asp 486, Glu 434, and Lys 338) through Trp 484, which are believed to be important for processing events.  **Val403Met** is believed to affect correct folding of the C-terminal domain of NLGN and prevent formation of the functional dimer. **The Lys378Arg mutation** which interacts with the Cys-loop Asp 122 through Van der Waals contacts could disrupt the Cys-loop reducing NLGN structural integrity. These mutations do not entirely disrupt NLGNs interaction with NRXN, but do impact NLGN in the subtle ways from which Autism likely arises.<ref name="Fabrichny"/>  
====Neuroligin-Neurexin Interaction====
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<scene name='Neuroligin-Neurexin_Interaction/Combo/3'>NRXN-beta-1 is bound</scene> through its <scene name='Neuroligin-Neurexin_Interaction/Combo_hyper/1'>hypervariable loop edge</scene> to the <scene name='Neuroligin-Neurexin_Interaction/Combo_electro/2'>electronegative surface</scene> of the NLGN-4 molecule, <scene name='Neuroligin-Neurexin_Interaction/Combo_total/1'>opposite the Cys-loop</scene>. The NRXN-NLGN interface is established by both indirect and direct interactions. Indirect interactions include <scene name='Neuroligin-Neurexin_Interaction/Calcium/4'>coordination of a divalent calcium cation</scene> by residues Asp 137, Asn 238, Val 154 and Ile 236 of NRXN-Beta1 and residues Gln 359 and Gly 360 of NLGN-4. <scene name='Neuroligin-Neurexin_Interaction/Interactions/2'>Direct interactions</scene> between NRXN and NLGN include extensive hydrogen bonding and Van der Waals contacts as well as <scene name='Neuroligin-Neurexin_Interaction/Salt_bridges/1'>salt bridges</scene> between residues NRXN-Arg 109 & NLGN-Glu 270 and NRXN-Arg232 & NLGN Asp 351. The vast majority of these interactions are conserved among all neuroligin types.<ref name="Fabrichny"/>
 
====Mutations Leading To Neurodevelopmental Disorders====
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Several <scene name='Neuroligin-Neurexin_Interaction/Mutation_dimer/3'>point mutations</scene> (R437C (451 in NLGN 3), G99S, K378R, & V403M) within NLGN have been positively linked with Autism Spectrum Disorders. Although these mutations are remote from the NLGN-NRXN interface, conclusions can be drawn as to their impact on the function of NLGN. <scene name='Neuroligin-Neurexin_Interaction/Mutation_437/1'>Arg437Cys</scene>, a mutation shown to result in “savant” like attributes in mice, is believed to increase retention of NLGN in the endoplasmic reticulum preventing correct positioning at the cell surface. It could also disrupt a <scene name='Neuroligin-Neurexin_Interaction/Mutation_437_network/1'>dense network of charged residues</scene> (Asp 388, Asp 486, Glu 434, and Lys 338) through Trp 484, which likely play an important role in  processing events.  <scene name='Neuroligin-Neurexin_Interaction/Mutation_403/1'>Val403Met</scene> is believed to affect correct folding of the C-terminal domain of NLGN and prevent formation of the functional dimer. The <scene name='Neuroligin-Neurexin_Interaction/Mutation_378/1'>Lys378Arg mutation</scene> which interacts with the <scene name='Neuroligin-Neurexin_Interaction/Mutation_378_interaction/2'>Cys-loop Asp 122</scene> through Van der Waals contacts could disrupt the Cys-loop deleteriously impacting NLGN structural integrity. These mutations do not entirely disrupt NLGNs interaction with NRXN, but do impact NLGN in the subtle ways from which [[Neurodevelopmental Disorders|autism]] likely arises.<ref name="Fabrichny"/>  
__NOTOC__
__NOEDITSECTION__
</StructureSection>
</StructureSection>
==Page Development==
This article was developed based on lectures given in Chemistry 543 by Prof. Clarence E. Schutt at Princeton University.


==Additional Structures of Neuroligin and Neurexin==
==Additional Structures of Neuroligin and Neurexin==

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

David Canner, Michal Harel